FR2164856B1 - - Google Patents

Info

Publication number
FR2164856B1
FR2164856B1 FR7245867A FR7245867A FR2164856B1 FR 2164856 B1 FR2164856 B1 FR 2164856B1 FR 7245867 A FR7245867 A FR 7245867A FR 7245867 A FR7245867 A FR 7245867A FR 2164856 B1 FR2164856 B1 FR 2164856B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7245867A
Other versions
FR2164856A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruppo Lepetit SpA
Original Assignee
Gruppo Lepetit SpA
Lepetit SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruppo Lepetit SpA, Lepetit SpA filed Critical Gruppo Lepetit SpA
Publication of FR2164856A1 publication Critical patent/FR2164856A1/fr
Application granted granted Critical
Publication of FR2164856B1 publication Critical patent/FR2164856B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FR7245867A 1971-12-23 1972-12-22 Expired FR2164856B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT3283871 1971-12-23

Publications (2)

Publication Number Publication Date
FR2164856A1 FR2164856A1 (fr) 1973-08-03
FR2164856B1 true FR2164856B1 (fr) 1975-10-17

Family

ID=11236012

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7245867A Expired FR2164856B1 (fr) 1971-12-23 1972-12-22

Country Status (11)

Country Link
US (1) US3852450A (fr)
JP (1) JPS535381B2 (fr)
AU (1) AU466967B2 (fr)
BE (1) BE793253A (fr)
CA (1) CA985628A (fr)
FR (1) FR2164856B1 (fr)
GB (1) GB1346710A (fr)
IE (1) IE37080B1 (fr)
IL (1) IL41009A (fr)
NL (1) NL152755B (fr)
ZA (1) ZA728947B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209513A (en) 1974-02-14 1980-06-24 Burroughs Wellcome Co. Tablet formulation
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes
US4125610A (en) * 1977-07-27 1978-11-14 Bristol-Myers Company Antibacterial compositions
US4762836A (en) * 1983-02-02 1988-08-09 Eli Lilly And Company Aromatase inhibitors
CA2095518A1 (fr) * 1990-11-14 1992-05-15 Jeffrey M. Blaney Inhibition specifique de la dihydrofolate-reductase et composes utilises
AU2002350212A1 (en) * 2001-11-20 2003-06-10 Dana Farber Cancer Institute Pharmaceutically active compounds and methods of use thereof
AU2003234670B2 (en) 2002-05-24 2010-06-10 Angiotech International Ag Compositions and methods for coating medical implants
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
CN109789125B (zh) * 2016-08-16 2022-10-18 罗切斯特大学 含有基于多粘菌素b/甲氧苄啶的治疗剂的药物组合物

Also Published As

Publication number Publication date
IE37080B1 (en) 1977-04-27
ZA728947B (en) 1973-09-26
JPS535381B2 (fr) 1978-02-27
FR2164856A1 (fr) 1973-08-03
IE37080L (en) 1973-06-23
IL41009A0 (en) 1973-02-28
AU4960372A (en) 1974-06-06
GB1346710A (en) 1974-02-13
NL152755B (nl) 1977-04-15
US3852450A (en) 1974-12-03
AU466967B2 (en) 1975-11-13
IL41009A (en) 1975-12-31
NL7217354A (fr) 1973-06-26
JPS4868721A (fr) 1973-09-19
DE2259624A1 (de) 1973-06-28
BE793253A (fr) 1973-04-16
CA985628A (en) 1976-03-16
DE2259624B2 (de) 1975-10-23

Similar Documents

Publication Publication Date Title
ATA136472A (fr)
FR2164856B1 (fr)
AR196074A1 (fr)
AU2658571A (fr)
AU2691671A (fr)
AU3005371A (fr)
AU2485671A (fr)
AU2742671A (fr)
AU2564071A (fr)
AU2684071A (fr)
AR192311Q (fr)
AU2885171A (fr)
AU2486471A (fr)
AU2684171A (fr)
AU2473671A (fr)
AU2456871A (fr)
AU2455871A (fr)
AU2415871A (fr)
AU2669471A (fr)
AU2399971A (fr)
AU1109576A (fr)
AU2588771A (fr)
AU2740271A (fr)
AR202997Q (fr)
AR199640Q (fr)